Yingying Shi1, Zhongdi Chu2, Liang Wang1, Qinqin Zhang2, William Feuer1, Luis de Sisternes3, Mary K Durbin3, Giovanni Gregori1, Ruikang K Wang2, Philip J Rosenfeld4. 1. Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA. 2. Department of Bioengineering, University of Washington, Seattle, Washington, USA. 3. Research and Development, Carl Zeiss Meditec, Inc, Dublin, California, USA. 4. Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA. Electronic address: prosenfeld@miami.edu.
Abstract
PURPOSE: A compensation strategy that was developed to measure the choriocapillaris (CC) flow deficits (FDs) under drusen was tested in eyes with large drusen from age-related macular degeneration (AMD) before and after the drusen spontaneously resolved without evidence of disease progression. DESIGN: Prospective, observational consecutive case series. METHODS: Patients with AMD were enrolled in a prospective swept-source optical coherence tomography (SS-OCT) imaging study. Consecutive eyes with large drusen were followed, and eyes that underwent spontaneous collapse of drusen without evidence of disease progression were identified retrospectively. The drusen-resolved regions were manually outlined. CC FDs were measured using a previously published compensation strategy that adjusted for the decreased signal intensity underlying drusen. Both the percentage of FDs (FD%) and the mean FD sizes (MFDSs) were measured before and after drusen resolution. RESULTS: Resolution of drusen was identified in 8 eyes from 8 patients. The average interval between the 2 visits was 7.8 months. The average drusen volumes measured between visits were 0.23 and 0.04 mm3, respectively. After the drusen resolved, the average follow-up time without evidence of disease progression was 10.1 months. When the 2 visits were compared, there were no statistically significant differences in any of the CC parameters within the drusen resolved regions once the compensation strategy was applied (all P values >.22). CONCLUSIONS: In this naturally occurring experiment in which drusen collapsed without evidence of disease progression, the CC parameters were similar once our compensation strategy was applied both before and after the drusen resolved.
PURPOSE: A compensation strategy that was developed to measure the choriocapillaris (CC) flow deficits (FDs) under drusen was tested in eyes with large drusen from age-related macular degeneration (AMD) before and after the drusen spontaneously resolved without evidence of disease progression. DESIGN: Prospective, observational consecutive case series. METHODS:Patients with AMD were enrolled in a prospective swept-source optical coherence tomography (SS-OCT) imaging study. Consecutive eyes with large drusen were followed, and eyes that underwent spontaneous collapse of drusen without evidence of disease progression were identified retrospectively. The drusen-resolved regions were manually outlined. CC FDs were measured using a previously published compensation strategy that adjusted for the decreased signal intensity underlying drusen. Both the percentage of FDs (FD%) and the mean FD sizes (MFDSs) were measured before and after drusen resolution. RESULTS: Resolution of drusen was identified in 8 eyes from 8 patients. The average interval between the 2 visits was 7.8 months. The average drusen volumes measured between visits were 0.23 and 0.04 mm3, respectively. After the drusen resolved, the average follow-up time without evidence of disease progression was 10.1 months. When the 2 visits were compared, there were no statistically significant differences in any of the CC parameters within the drusen resolved regions once the compensation strategy was applied (all P values >.22). CONCLUSIONS: In this naturally occurring experiment in which drusen collapsed without evidence of disease progression, the CC parameters were similar once our compensation strategy was applied both before and after the drusen resolved.
Authors: Zohar Yehoshua; Fenghua Wang; Philip J Rosenfeld; Fernando M Penha; William J Feuer; Giovanni Gregori Journal: Ophthalmology Date: 2011-07-02 Impact factor: 12.079
Authors: Enrico Borrelli; Eric H Souied; K Bailey Freund; Giuseppe Querques; Alexandra Miere; Orly Gal-Or; Riccardo Sacconi; SriniVas R Sadda; David Sarraf Journal: Retina Date: 2018-10 Impact factor: 4.256
Authors: R S Ramrattan; T L van der Schaft; C M Mooy; W C de Bruijn; P G Mulder; P T de Jong Journal: Invest Ophthalmol Vis Sci Date: 1994-05 Impact factor: 4.799
Authors: WooJhon Choi; Kathrin J Mohler; Benjamin Potsaid; Chen D Lu; Jonathan J Liu; Vijaysekhar Jayaraman; Alex E Cable; Jay S Duker; Robert Huber; James G Fujimoto Journal: PLoS One Date: 2013-12-11 Impact factor: 3.240
Authors: Zhongdi Chu; Yingying Shi; Xiao Zhou; Liang Wang; Hao Zhou; Rita Laiginhas; Qinqin Zhang; Yuxuan Cheng; Mengxi Shen; Luis de Sisternes; Mary K Durbin; William Feuer; Giovanni Gregori; Philip J Rosenfeld; Ruikang K Wang Journal: Am J Ophthalmol Date: 2021-11-13 Impact factor: 5.258
Authors: Eric M Moult; Yingying Shi; Qinqin Zhang; Liang Wang; Rahul Mazumder; Siyu Chen; Zhongdi Chu; William Feuer; Nadia K Waheed; Giovanni Gregori; Ruikang K Wang; Philip J Rosenfeld; James G Fujimoto Journal: Biomed Opt Express Date: 2021-07-01 Impact factor: 3.732
Authors: Hao Zhou; Jie Lu; Kelly Chen; Yingying Shi; Giovanni Gregori; Philip J Rosenfeld; Ruikang K Wang Journal: Quant Imaging Med Surg Date: 2022-05
Authors: Zhongdi Chu; Qinqin Zhang; Giovanni Gregori; Philip J Rosenfeld; Ruikang K Wang Journal: Am J Ophthalmol Date: 2020-09-04 Impact factor: 5.258